Alison Schram, MD
Internal Medicine · New York, NYNPI 1285996975
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,810 of the $9,175 with a category attached, or 96.0%. Boehringer Ingelheim International GmbH accounts for 66.4% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $8,936, more than ten times the $119 reported in 2019. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 6 payments — averaging $1529.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$6K
- Day One Biopharmaceuticals$3K
- AbbVie$120
- Puma Biotechnology, Inc.$119
- Partner Therapeutics, Inc.$83
- Beone Medicines USA, Inc.$43
Across 61 payments — averaging $47,085 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$1.2M
- Eli Lilly$630K
- Partner Therapeutics, Inc.$412K
- Boehringer Ingelheim$296K
- Boehringer Ingelheim Pharma GmbH & Co.kg$269K
- Merck$62K
What the payments were for
- Consulting fees$8,81096%
- Food & beverage$3654%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 1 | $6,090 |
| Day One Biopharmaceuticals | 1 | $2,720 |
| AbbVie | 1 | $120 |
| Puma Biotechnology, Inc. | 1 | $119 |
| Partner Therapeutics, Inc. | 1 | $83 |
| Beone Medicines USA, Inc. | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,175 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LynparzaOlaparib | 27 | $290,614 |
| Dexamethasone | 42 | $1,096 |
| Letrozole | 32 | $484 |
| Ondansetron Hcl | 26 | $289 |
| Losartan Potassium | 16 | $199 |
| Gabapentin | 17 | $111 |
| Lorazepam | 19 | $100 |
| Oxycodone Hcl | 12 | $99 |
| Amlodipine Besylate | 23 | $80 |
| Levothyroxine Sodium | 19 | $52 |
| Montelukast Sodium | 18 | $43 |
| Prednisone | 15 | $22 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.